436 related articles for article (PubMed ID: 29854817)
1. The Relationship between Frequently Used Glucose-Lowering Agents and Gut Microbiota in Type 2 Diabetes Mellitus.
Lv Y; Zhao X; Guo W; Gao Y; Yang S; Li Z; Wang G
J Diabetes Res; 2018; 2018():1890978. PubMed ID: 29854817
[TBL] [Abstract][Full Text] [Related]
2. Lactobacillus acidophilus alleviates type 2 diabetes by regulating hepatic glucose, lipid metabolism and gut microbiota in mice.
Yan F; Li N; Shi J; Li H; Yue Y; Jiao W; Wang N; Song Y; Huo G; Li B
Food Funct; 2019 Sep; 10(9):5804-5815. PubMed ID: 31461095
[TBL] [Abstract][Full Text] [Related]
3. New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes.
Chen Y; Wang M
Drug Des Devel Ther; 2021; 15():4849-4863. PubMed ID: 34876807
[TBL] [Abstract][Full Text] [Related]
4. The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases.
Pascale A; Marchesi N; Govoni S; Coppola A; Gazzaruso C
Curr Opin Pharmacol; 2019 Dec; 49():1-5. PubMed ID: 31015106
[TBL] [Abstract][Full Text] [Related]
5. Hypoglycemic and Hypolipidemic Mechanism of Tea Polysaccharides on Type 2 Diabetic Rats via Gut Microbiota and Metabolism Alteration.
Li H; Fang Q; Nie Q; Hu J; Yang C; Huang T; Li H; Nie S
J Agric Food Chem; 2020 Sep; 68(37):10015-10028. PubMed ID: 32811143
[TBL] [Abstract][Full Text] [Related]
6. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
[TBL] [Abstract][Full Text] [Related]
7. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.
Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D
Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709
[TBL] [Abstract][Full Text] [Related]
8. 16S rRNA Sequencing and Metagenomics Study of Gut Microbiota: Implications of BDB on Type 2 Diabetes Mellitus.
Zhang L; Luo J; Li X; Guo S; Shi D
Mar Drugs; 2020 Sep; 18(9):. PubMed ID: 32957565
[TBL] [Abstract][Full Text] [Related]
9. Insulin Sensitivity-Enhancing Activity of Phlorizin Is Associated with Lipopolysaccharide Decrease and Gut Microbiota Changes in Obese and Type 2 Diabetes (db/db) Mice.
Mei X; Zhang X; Wang Z; Gao Z; Liu G; Hu H; Zou L; Li X
J Agric Food Chem; 2016 Oct; 64(40):7502-7511. PubMed ID: 27635781
[TBL] [Abstract][Full Text] [Related]
10. Metformin: old friend, new ways of action-implication of the gut microbiome?
Rodriguez J; Hiel S; Delzenne NM
Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):294-301. PubMed ID: 29634493
[TBL] [Abstract][Full Text] [Related]
11. Considering gut microbiota in treatment of type 2 diabetes mellitus.
Adeshirlarijaney A; Gewirtz AT
Gut Microbes; 2020 May; 11(3):253-264. PubMed ID: 32005089
[TBL] [Abstract][Full Text] [Related]
12. Corni Fructus as a Natural Resource Can Treat Type 2 Diabetes by Regulating Gut Microbiota.
Niu D; An S; Chen X; Bi H; Zhang Q; Wang T; Han B; Zhang H; Kang J
Am J Chin Med; 2020; 48(6):1385-1407. PubMed ID: 32907359
[TBL] [Abstract][Full Text] [Related]
13. Response of gut microbiota in type 2 diabetes to hypoglycemic agents.
Zhang F; Wang M; Yang J; Xu Q; Liang C; Chen B; Zhang J; Yang Y; Wang H; Shang Y; Wang Y; Mu X; Zhu D; Zhang C; Yao M; Zhang L
Endocrine; 2019 Dec; 66(3):485-493. PubMed ID: 31410749
[TBL] [Abstract][Full Text] [Related]
14. Metformin and gut microbiota: their interactions and their impact on diabetes.
Vallianou NG; Stratigou T; Tsagarakis S
Hormones (Athens); 2019 Jun; 18(2):141-144. PubMed ID: 30719628
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges.
Liu Y; Lou X
Clinics (Sao Paulo); 2020; 75():e1277. PubMed ID: 31939557
[TBL] [Abstract][Full Text] [Related]
16. Modulating gut microbiota as an anti-diabetic mechanism of berberine.
Han J; Lin H; Huang W
Med Sci Monit; 2011 Jul; 17(7):RA164-7. PubMed ID: 21709646
[TBL] [Abstract][Full Text] [Related]
17. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
[TBL] [Abstract][Full Text] [Related]
18. JinQi Jiangtang Tablet Regulates Gut Microbiota and Improve Insulin Sensitivity in Type 2 Diabetes Mice.
Cao Y; Yao G; Sheng Y; Yang L; Wang Z; Yang Z; Zhuang P; Zhang Y
J Diabetes Res; 2019; 2019():1872134. PubMed ID: 30733971
[TBL] [Abstract][Full Text] [Related]
19. The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus.
Lee CB; Chae SU; Jo SJ; Jerng UM; Bae SK
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808194
[TBL] [Abstract][Full Text] [Related]
20. Featured article: Structure moderation of gut microbiota in liraglutide-treated diabetic male rats.
Zhang Q; Xiao X; Zheng J; Li M; Yu M; Ping F; Wang T; Wang X
Exp Biol Med (Maywood); 2018 Jan; 243(1):34-44. PubMed ID: 29171288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
